Endo Pharma ENDP reports its Q4 adjusted EPS at $1.06, beating the consensus of $0.96. ENDP reports its Q4 revenue at $511 million, versus the consensus of $482.76 million.
ENDP shares gained 1.95% to $35.00 in pre-market trading.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
